Prevention of disseminated candidiasis

Prevention of disseminated candidiasis refers to prophylactic intervention against the systemic spread of *Candida* species into the bloodstream and deep visceral organs This clinical strategy targets high-risk patient populations, such as critically ill intensive care patients, individuals undergoing hematopoietic stem cell or solid organ transplantation, patients with profound neutropenia, and premature neonates Pathophysiologically, disruption of mucosal or cutaneous barriers permits commensa...

Prevention of disseminated candidiasis refers to prophylactic intervention against the systemic spread of *Candida* species into the bloodstream and deep visceral organs Pathophysiologically, disruption of mucosal or cutaneous barriers permits commensal *Candida* to enter the vasculature, leading to candidemia, septic shock, and secondary seeding of distant tissues including the liver, spleen, kidneys, eyes, and central nervous system

This clinical strategy targets high-risk patient populations, such as critically ill intensive care patients, individuals undergoing hematopoietic stem cell or solid organ transplantation, patients with profound neutropenia, and premature neonates Prophylaxis aims to inhibit fungal replication and tissue invasion before life-threatening hematogenous dissemination develops

This clinical strategy targets high-risk patient populations, such as critically ill intensive care patients, individuals undergoing hematopoietic stem cell or solid organ transplantation, patients with profound neutropenia, and premature neonates Prophylaxis aims to inhibit fungal replication and tissue invasion before life-threatening hematogenous dissemination develops

Pathophysiologically, disruption of mucosal or cutaneous barriers permits commensal *Candida* to enter the vasculature, leading to candidemia, septic shock, and secondary seeding of distant tissues including the liver, spleen, kidneys, eyes, and central nervous system